Lupus myocarditis receiving the rituximab therapy—a monocentric retrospective study

Clinical Rheumatology

Volumn 37, Issue 6, 2018, Pages 1701-1707

  Wang, Chrong Reen ^a   Tsai, Yi Shan ^a   Li, Wei Ting ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Myocarditis; Rituximab; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CD19 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; RITUXIMAB; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; B LYMPHOCYTE; CARDIOVASCULAR MAGNETIC RESONANCE; COHORT ANALYSIS; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; HAN CHINESE; HEART FUNCTION; HUMAN; LUPUS MYOCARDITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL DEPLETION; CARDIAC IMAGING; COMPLICATION; DIAGNOSTIC IMAGING; DRUG EFFECT; HEART; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; YOUNG ADULT;

ADULT; ANTIRHEUMATIC AGENTS; CARDIAC IMAGING TECHNIQUES; FEMALE; HEART; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYOCARDITIS; RETROSPECTIVE STUDIES; RITUXIMAB; YOUNG ADULT;

EID: 85039990687     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-017-3971-4     Document Type: Article

References (20)

1. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M (2005) Cardiac involvement in systemic lupus erythematosus. Lupus 14(9):683–686. 10.1191/0961203305lu2200oa
2. Chen J, Tang Y, Zhu M, Xu A (2016) Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis. Clin Rheumatol 35:2437–2448
3. Miner JJ, Kim AH (2014) Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin N Am 40(1):51–60. 10.1016/j.rdc.2013.10.003
4. Apte M, Jr MGG, Vilá LM, Kaslow RA, Alarcón GS, Reveille JD, LUMINA Study Group (2008) Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort. Rheumatology 47:362–367
5. Zawadowski GM, Klarich KW, Moder KG, Edwards WD, Cooper LT Jr (2012) A contemporary case series of lupus myocarditis. Lupus 21(13):1378–1384. 10.1177/0961203312456752
6. Thomas G, Cohen Aubart F, Chiche L, et al (2017) Lupus myocarditis: initial presentation and long term outcomes in a multicentric series of 29 patients. J Rheumatol44:24–32
7. Hahn BH, McMathon MA, Wilkinson A et al (2012) American College of Rheumatology Guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 64:797–808
8. Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg da, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT, European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association. (2012) Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71:1771–1782, 11, DOI: 10.1136/annrheumdis-2012-201940
9. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. 10.1002/art.1780400928
10. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM, European Society of Cardiology Working Group on Myocardial and Pericardial Diseases (2013) Current state of knowledge on etiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34(33):2636–2648. 10.1093/eurheartj/eht210
11. Gladman DD, Ibañez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002:288–291
12. Mavrogeni SI, Sfikakis PP, Kitas GD, Kolovou G, Tektonidou MG (2016) Cardiac involvement in antiphospholipid syndrome: the diagnostic role of noninvasive cardiac imaging. Semin Arthritis Rheum 45(5):611–616. 10.1016/j.semarthrit.2015.09.005
13. Ramos-Casals M, Soto MJ, Cuadrado MJ, Khamashta MA (2009) Rituximab in systemic lupus erythematosus: a systematic review of off-label use in 188 cases. Lupus 18(9):767–776. 10.1177/0961203309106174
14. Aggarwal P, Singh S, Suri D, Rawat A, Narula N, ManojKumar R (2012) Rituximab in childhood lupus myocarditis. Rheumatol Int 32:1843–1844
15. Du Toit R, Herbst PG, van Rensburg A, du Plessis LM, Reuter H, Doubell AF (2017) Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa. Lupus 26(1):38–47. 10.1177/0961203316651741
16. Zhang L, Zhu YL, Li MT, Gao N, You X, Wu QJ, Su JM, Shen M, Zhao LD, Liu JJ, Zhang FC, Zhao Y, Zeng XF (2015) Lupus myocarditis: a case-control study from China. Chin Med J 128(19):2588–2594. 10.4103/0366-6999.166029
17. Bidani AK, Roberts JL, Schwartz MM, Lewis EJ (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69(6):849–858. 10.1016/S0002-9343(80)80010-6
18. Ye Y, Qian J, Gu Y, Chen X, Ye S (2011) Rituximab in the treatment of severe lupus myelopathy. Clin Rheumatol 30:981–986
19. Cobo-Ibáñez T, Loza-Santamaría E, Pego-Reigosa JM, Marqués AO, Rúa-Figueroa Í, Fernández-Nebro A, Cáliz RC, López Longo FJ, Muñoz-Fernández S (2014) Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review. Semin Arthritis Rheum 44(2):175–185. 10.1016/j.semarthrit.2014.04.002
20. Wang CR, Liu MF (2016) Rituximab usage in systemic lupus erythematosus-associated antiphospholipid syndrome: a single-center experience. Semin Arthritis Rheum 46(1):102–108. 10.1016/j.semarthrit.2016.02.002